US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Novo Nordisk A/S B Shares ADRhedged

21.79

+0.11690.54%

Post-market: 21.790.00000.00%16:04 EDT

Volume:65

Turnover:1K

Market Cap:3.70M

PE:- -

High:21.79

Open:21.67

Low:21.79

Close:21.67

52wk High:34.36

52wk Low:19.00

Shares:170.00K

Float Shares:170.00K

Volume Ratio:0.03

T/O Rate:0.04%

Dividend:1.56

Dividend Rate:7.16%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Novo Nordisk price target lowered to DKK 296 from DKK 310 at Citi

Novo Nordisk A/S Series B Stock Rises Friday, Outperforms Market

1 Drugs Could Ease Back and Knee Pain, but Doctors Say There are Risks for Older Adults

Novo Nordisk's Wegovy Pill to Buoy Sales, but Investors Likely to Stay Sidelined

Citi Lowers Novo Nordisk Price Target to DKK 296: Oral Weight-Loss Pill Sales Outlook Improves, but Margin Growth Remains Weak

Novo Nordisk Wraps Up Real World Joint Health Study for Esperoct in Haemophilia A

1s Could Offer Unexpected Relief from Back and Knee Pain, but Doctors Urge Caution

Cboe data suggests bullish flow in Novo Nordisk with shares up 1.69%

Novo Nordisk A/S Series B Stock Rises Wednesday, Outperforms Market

Novo Nordisk call volume above normal and directionally bullish

European Equities Traded in US as ADRs Fall in Wednesday Trading

MT Newswires Live

Deutsche Bank Keeps Their Sell Rating on Novo Nordisk (0QIU)

Why Vaxcyte Chose A 1.5% Convertible

Novo Nordisk Probes Patient Priorities in German Hemophilia A Study

From Lilly Deal to Market Darling: Inside Ginkgo's 120% Monthly Run

Bellwether Stocks Movement

Cboe data shows mixed options sentiment in Novo Nordisk with shares down 0.47%

Novo Nordisk A/S Series B Stock Falls Monday, Underperforms Market

J.P. Morgan Sticks to Their Hold Rating for Novo Nordisk (0QIU)

Novo Nordisk Could Raise Guidance Alongside Strong Results

Merck Doubled Off Its Lows — And Analysts Still See More Room

Bellwether Stocks Movement

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/NVOH/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"NVOH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NVOH\",,,,,undefined,":{"symbol":"NVOH","market":"US","secType":"STK","nameCN":"Novo Nordisk A/S B Shares ADRhedged","latestPrice":21.7869,"timestamp":1791576000000,"preClose":21.67,"halted":0,"volume":65,"hourTrading":{"tag":"盘后","latestPrice":21.7869,"preClose":21.7869,"latestTime":"16:04 EDT","volume":2,"amount":43.5738,"timestamp":1791576245583,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.005394554683894673,"floatShares":170001,"shares":170001,"eps":0,"marketStatus":"Post-Mkt","change":0.1169,"latestTime":"10-09 19:46:48 EDT","open":21.67,"high":21.7869,"low":21.7869,"amount":1413,"amplitude":0,"askPrice":29.3,"askSize":100,"bidPrice":18.27,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1791590400000},"marketStatusCode":4,"adr":0,"exchange":"ARCA","adjPreClose":21.67,"nav":21.635165,"aum":3677999.685165,"dividendRate":0.071607,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":21.7869,"preClose":21.7869,"latestTime":"16:04 EDT","volume":2,"amount":43.5738,"timestamp":1791576245583,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.029041,"impliedVol":0.485,"impliedVolPercentile":0.9248},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NVOH\",,,,,undefined,":{"symbol":"NVOH","floatShares":170001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.029041,"shares":170001,"dividePrice":1.5601,"high":21.7869,"amplitude":0,"preClose":21.67,"low":21.7869,"week52Low":19,"pbRate":"--","week52High":34.36,"institutionHeld":0,"latestPrice":21.7869,"eps":0,"divideRate":0.071607,"volume":65,"delay":0,"ttmEps":0,"open":21.67,"prevYearClose":27.4362,"prevWeekClose":20.9938,"prevMonthClose":21.2125,"prevQuarterClose":21.2125,"fiveDayClose":20.9938,"twentyDayClose":23.4261,"sixtyDayClose":27.8996},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NVOH\",params:#limit:5,,,undefined,":[{"date":"2026-09-16","symbol":"NVOH","amount":0.02979,"announcedDate":"2026-09-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-16","defaultRemindTime":1789565400000,"name":"Novo Nordisk A/S B Shares ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-23","payableDate":"2026-09-16","currency":"USD","dateTimestamp":1789531200000,"payDate":"2026-09-23"},{"date":"2026-06-16","symbol":"NVOH","amount":0.76666,"announcedDate":"2026-06-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-16","defaultRemindTime":1781616600000,"name":"Novo Nordisk A/S B Shares ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-23","payableDate":"2026-06-16","currency":"USD","dateTimestamp":1781582400000,"payDate":"2026-06-23"},{"date":"2026-03-16","symbol":"NVOH","amount":0.27495,"announcedDate":"2026-03-13","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-16","defaultRemindTime":1773667800000,"name":"Novo Nordisk A/S B Shares ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-23","payableDate":"2026-03-16","currency":"USD","dateTimestamp":1773633600000,"payDate":"2026-03-23"},{"date":"2025-12-16","symbol":"NVOH","amount":0.48798,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"Novo Nordisk A/S B Shares ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-24"},{"date":"2025-09-16","symbol":"NVOH","amount":0.16566,"announcedDate":"2025-09-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-16","defaultRemindTime":1758029400000,"name":"Novo Nordisk A/S (B Shares) ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-23","payableDate":"2025-09-16","currency":"USD","dateTimestamp":1757995200000,"payDate":"2025-09-23"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NVOH\",market:\"US\",,,undefined,":[{"executeDate":"2025-09-16","recordDate":"2025-09-16","paymentDate":"2025-09-23","value":0.16566,"currency":"USD"},{"executeDate":"2025-12-16","recordDate":"2025-12-16","paymentDate":"2025-12-24","value":0.48798,"currency":"USD"},{"executeDate":"2026-03-16","recordDate":"2026-03-16","paymentDate":"2026-03-23","value":0.27495,"currency":"USD"},{"executeDate":"2026-06-16","recordDate":"2026-06-16","paymentDate":"2026-06-23","value":0.76666,"currency":"USD"},{"executeDate":"2026-09-16","recordDate":"2026-09-16","paymentDate":"2026-09-23","value":0.02979,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NVOH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NVOH\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2674286599","title":"Novo Nordisk price target lowered to DKK 296 from DKK 310 at Citi","url":"https://stock-news.laohu8.com/highlight/detail?id=2674286599","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674286599?lang=en_us&edition=fundamental","pubTime":"2026-10-10 00:31","pubTimestamp":1791563467,"startTime":"0","endTime":"0","summary":"Citi analyst Graham Parry lowered the firm’s price target on Novo Nordisk (NVO) to DKK 296 from DKK 310 and keeps a Neutral rating on the shares. P...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/novo-nordisk-price-target-lowered-to-dkk-296-from-dkk-310-at-citi-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/novo-nordisk-price-target-lowered-to-dkk-296-from-dkk-310-at-citi-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NVOC","BK4588","BK4585","IE00BKVL7J92.USD","LU1093756325.SGD","OZEM","PPH","IE00BZ1G4Q59.USD","NVOH","THNR","BK4532","BK4599","LU0154236417.USD","LU1093756168.USD","NVOX","NVO","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674863271","title":"Novo Nordisk A/S Series B Stock Rises Friday, Outperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2674863271","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674863271?lang=en_us&edition=fundamental","pubTime":"2026-10-10 00:03","pubTimestamp":1791561780,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of Novo Nordisk A/S Series B advanced 2.1% to DKK255.25 Friday on what proved to be an overall positive trading session for the stock market, with the OMX Nordic 40 Index rising 1.5% to 2,615.74.The company closed DKK154.70 below its 52-week high of DKK409.95, which the company achieved on January 23, 2026.Trading volume was 5,041,888, compared to the 50-day average trading volume of 5,080,254.Data source: Dow Jones Market Data, FactSet","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVOX","BK4007","THNR","OZEM","LU1093756325.SGD","BK4532","LU0154236417.USD","NVOC","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","BK4588","BK5011","LU1093756168.USD","NVOH","BK4585","NVO","0QIU.UK","BK4599","PPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674785071","title":"1 Drugs Could Ease Back and Knee Pain, but Doctors Say There are Risks for Older Adults","url":"https://stock-news.laohu8.com/highlight/detail?id=2674785071","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674785071?lang=en_us&edition=fundamental","pubTime":"2026-10-09 22:38","pubTimestamp":1791556680,"startTime":"0","endTime":"0","summary":"Losing weight is good for the spine. However, physicians say rapid weight loss can lead to issues with bone quality in certain people.Doctors say that some patients who are taking GLP-1 drugs to lose ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2491049909.HKD","RXL","ILDR","SG9999001176.USD","SGXZ99366536.SGD","LU1917777945.USD","LU0471298777.SGD","LU0471298694.HKD","LU1127390331.HKD","THNR","SG9999014898.SGD","LU0323591593.USD","BK4532","BK4533","LU0094547139.USD","LU0203201768.USD","LU2211815571.USD","LU2023250504.SGD","LU1232071149.USD","PJP","SGXZ51526630.SGD","XLV","IE00BKDWB100.SGD","LU1868836914.USD","LU2361045086.USD","IE0001KFT4U8.USD","LU0787776722.HKD","LU1988902786.USD","LU1979441026.SGD","IE00BFSS7M15.SGD","IE00BFSS8Q28.SGD","BK4588","LU2468319806.SGD","LU2089984988.USD","LU2456880835.USD","IHE","LU0320765992.SGD","FHLC","SG9999018865.SGD","LU1868837136.USD","GDOC","LU2023251221.USD","LU2462591350.SGD","IE0009355771.USD","LU2746668461.USD","SG9999013999.USD","LU2471134952.CNY","SG9999018857.SGD","LU2896262040.SGD","SG9999001176.SGD","LU0225283273.USD","LU2237443465.HKD","GB00BDT5M118.USD","PPH","IE00B1BXHZ80.USD","LU2461242641.AUD","SG9999015945.SGD","SG9999015978.USD","LU0964807845.USD","IE00BKVL7J92.USD","LU0640476718.USD","LU1629891620.HKD","LU2491050071.SGD","SG9999017495.SGD","LU1035775433.USD","LU2168564065.EUR","LU0210536198.USD","LU1093756168.USD","LU2237438978.USD","IE00BJT1NW94.SGD","LU2168564149.EUR","LU2756315664.SGD","LU2750360997.AUD","IE00BJJMRX11.SGD","LLYX","LU1366192091.USD","LU0106261372.USD","BK4516","LU2106854487.HKD","NVOC","IYH","LU0354030511.USD","LU0672654240.SGD","LU1291159041.SGD","LU1868837300.USD","LU2552382215.SGD","LU0320765059.SGD","SG9999014880.SGD","LU1093756325.SGD","LU1804176565.USD","IE00B7KXQ091.USD","LU0889565916.HKD","LU0689472784.USD","IE00B4R5TH58.HKD","LU1023059063.AUD","LU2028103732.USD","LU2089284900.SGD","LU2168564495.EUR","LU2361044865.SGD","LU2089283258.USD","LU0154236417.USD","IE00B2B36J28.USD","LU1989771016.USD","LU2168563687.JPY","LU2264538146.SGD","LU2361044949.HKD","LU0823434583.USD","LU2746668974.SGD","LU2108987350.USD","LU1064131342.USD","IE00B4JS1V06.HKD","IE0002141913.USD","LU1145028129.USD","LU0158827948.USD","LU0417517546.SGD","FTXH","LU2750360641.GBP","MEDX","LU1548497426.USD","HRTS","LU2213496289.HKD","LU1057294990.SGD","LU0058720904.USD","BK4585","LU0353189680.USD","LU2602419157.SGD","SGXZ57979304.SGD","LU2236285917.USD","LU0820562030.AUD","LU1868836757.USD","IE00BZ1G4Q59.USD","LU2471134523.USD","LU2491050154.USD","ELIS","LU2237443622.USD","LU0133085943.USD","IE00B1XK9C88.USD","IE00BJJMRZ35.SGD","LU1720051017.SGD","LU0943347566.SGD","SG9999015986.USD","LLY","LLII","VHT","LU2112291526.USD","LU0820561909.HKD","IE00BJJMRY28.SGD","LU1814569148.SGD","LU0456855351.SGD","LU1691799644.USD","LU0882574055.USD","LLYZ","IE00BK4W5L77.USD","IE00BWXC8680.SGD","LU0234572021.USD","LU0198837287.USD","LU0385154629.USD","LU0114720955.EUR","LU1712237335.SGD","ELIL","LU2168564222.USD","AGNG","WDNA","SG9999014914.USD","LU2087625088.SGD","LU0345770308.USD","LU2471134796.USD","TMED","LU0079474960.USD","BK4581","IE00BN29S564.USD","LU0266013472.USD","LU2023250330.USD","SG9999015952.SGD","LU1720051108.HKD","MHIP","LU0708995401.HKD","LU1061106388.HKD","LU0882574139.USD","LU0238689110.USD","LU1551013425.SGD","LU1868836591.USD","SGXZ31699556.SGD","LU0820561818.USD","LU0466842654.USD","LU1267930730.SGD","LU2063271972.USD","LU0061475181.USD","LU2552382058.USD","LU1983299246.USD","LU2552382132.HKD","IE00BK4W5M84.HKD","LU2111349929.HKD","LU0097036916.USD","LU2237443895.HKD","LU0122379950.USD","LU1623119135.USD","LU0432979614.USD","CURE","LU1323610961.USD","NVOH","IE00BKPKM429.USD","LU1551013342.USD","SG9999014906.USD","LU0203202063.USD","LU1974910355.USD","LU2360106947.USD","SGXZ81514606.USD","LU0345770993.USD","LU0354030438.USD","LU0289739699.SGD","BK4007","MEDI","LU2357305700.SGD","LU2324357040.USD","LU0823416689.USD","LU0109391861.USD","IE0004445015.USD","LU1280957306.USD","LU2417539215.USD","LU2237443382.USD","IE0004445239.USD","LU2462157665.USD","LU2756315318.SGD","LU2237443978.SGD","BK4534","IE00BFTCPJ56.SGD","LU0006306889.USD","LU2265009873.SGD","TRUH","IE0005OL40V9.USD","CANC","NVO","LU2237443549.SGD","LU1069344957.HKD","LU0158827781.USD","LU0174119429.USD","LU2271345857.HKD","IXJ","OZEM","NVOX","LU0256863902.USD","IE00BJLML261.HKD","LU0109394709.USD","LU0823434740.USD","LU0786609619.USD","BK4599","IE00B775H168.HKD","LU0683600562.USD","LU2471134879.HKD","LU0256863811.USD","LU0353189763.USD","LU0316494557.USD","LU0096364046.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674832906","title":"Novo Nordisk's Wegovy Pill to Buoy Sales, but Investors Likely to Stay Sidelined","url":"https://stock-news.laohu8.com/highlight/detail?id=2674832906","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674832906?lang=en_us&edition=fundamental","pubTime":"2026-10-09 16:42","pubTimestamp":1791535320,"startTime":"0","endTime":"0","summary":"0842 GMT - Novo Nordisk third-quarter sales could come in just above consensus after the strong Wegovy pill launch in the U.K., Citi analysts write. The bank forecasts sales 1% ahead of consensus, with sales of the Wegovy pill posting a 16% beat, while adjusted operating income is likely to land only in line, due to higher research and development costs which will weigh on margins. While Citi expects a Wegovy pill beat would be welcome, it still sees poor visibility on injectable Wegovy pricing and growing long-term competition threats from Eli Lilly, Roche, Pfizer and AstraZeneca as likely to keep many investors on the sidelines. The bank lowers its target price to 296 Danish kroner from 310 kroner and keeps its neutral rating. Shares rise 1.3% to 253.15 kroner.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVOC","THNR","BK4599","BK4588","IE00BKVL7J92.USD","BK4585","NVO","NVOH","IE00BZ1G4Q59.USD","PPH","BK4007","BK4532","LU1093756168.USD","OZEM","LU1093756325.SGD","NVOX","LU0154236417.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118774782","title":"Citi Lowers Novo Nordisk Price Target to DKK 296: Oral Weight-Loss Pill Sales Outlook Improves, but Margin Growth Remains Weak","url":"https://stock-news.laohu8.com/highlight/detail?id=1118774782","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1118774782?lang=en_us&edition=fundamental","pubTime":"2026-10-09 14:30","pubTimestamp":1791527422,"startTime":"0","endTime":"0","summary":"Citi has cut its price target on Danish pharmaceutical company Novo Nordisk from DKK 310 to DKK 296, while maintaining a \"Neutral\" rating.The main reason is that Novo Nordisk expects its profit...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1506573853.SGD","LU2456880835.USD","LU0203345920.USD","LU1366192091.USD","PJP","PINK","MEDI","BK4566","LU1074936037.SGD","LU2125154935.USD","C","LU0310800965.SGD","LU0130102774.USD","LU0320765646.SGD","FTXO","LU2125154778.USD","NVOX","RSPH","LU0052756011.USD","LU2236285917.USD","LU1162221912.USD","TFNS","LU1791807156.HKD","IYH","BK4504","LU1144417596.USD","NVOC","NBDS","LU1244550221.USD","BK4207","LU0098860793.USD","FHLC","LU0128525689.USD","LU1201861249.SGD","LU0314106906.USD","LU2462157665.USD","XLVI","LU1267930227.SGD","CURE","BK4585","LU1244550494.USD","BK4588","FXH","LU0072461881.USD","LU0130517989.USD","IYF","LU0477156953.USD","LU2417539215.USD","BK4534","LU0203347892.USD","LU0980610538.SGD","TRUH","NVOH","LU1244550577.SGD","LU0106831901.USD","BK4559","LU0170899867.USD","LU2360032135.SGD","THNR","LU1668664300.SGD","IE00BSNM7G36.USD","LU0162691827.USD","BGIA","LU0648001328.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674009775","title":"Novo Nordisk Wraps Up Real World Joint Health Study for Esperoct in Haemophilia A","url":"https://stock-news.laohu8.com/highlight/detail?id=2674009775","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674009775?lang=en_us&edition=fundamental","pubTime":"2026-10-09 00:30","pubTimestamp":1791477020,"startTime":"0","endTime":"0","summary":"Novo Nordisk ($NVO) announced an update on their ongoing clinical study. The Novo Nordisk A/S observational study, officially titled “Non-Intervent...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/novo-nordisk-wraps-up-real-world-joint-health-study-for-esperoct-in-haemophilia-a?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/novo-nordisk-wraps-up-real-world-joint-health-study-for-esperoct-in-haemophilia-a?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4599","BK4588","LU1093756168.USD","NVOH","OZEM","IE00BZ1G4Q59.USD","THNR","BK4007","LU0154236417.USD","NVO","LU1093756325.SGD","NVOC","NVOX","PPH","IE00BKVL7J92.USD","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673072046","title":"1s Could Offer Unexpected Relief from Back and Knee Pain, but Doctors Urge Caution","url":"https://stock-news.laohu8.com/highlight/detail?id=2673072046","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673072046?lang=en_us&edition=fundamental","pubTime":"2026-10-08 20:30","pubTimestamp":1791462600,"startTime":"0","endTime":"0","summary":"Losing weight is good for the spine. However, physicians say rapid weight loss can lead to issues with bone quality, particularly in older adults.Doctors say that some patients who are taking GLP-1 dr","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B1BXHZ80.USD","LU1988902786.USD","LU2211815571.USD","LU1145028129.USD","SG9999015952.SGD","LU0234572021.USD","LU2462157665.USD","LU2168564495.EUR","LU2468319806.SGD","LU2112291526.USD","LU1035775433.USD","LU0225283273.USD","IE00BWXC8680.SGD","SGXZ99366536.SGD","LU2108987350.USD","LU2750360997.AUD","LU1629891620.HKD","LU1064131342.USD","PJP","CANC","LU2471134879.HKD","IE00BJJMRY28.SGD","LU0094547139.USD","LU1232071149.USD","LU2168564065.EUR","LU2462591350.SGD","LU2471134523.USD","LU2089284900.SGD","LU1868836591.USD","SGXZ51526630.SGD","IE00BJT1NW94.SGD","GB00BDT5M118.USD","IE00BJLML261.HKD","LU2271345857.HKD","LU1069344957.HKD","OZEM","IE0009355771.USD","NVOC","LU0354030511.USD","LU0158827781.USD","LU0320765059.SGD","LU2552382132.HKD","LU0820562030.AUD","LU1280957306.USD","LU2756315318.SGD","LU1720051017.SGD","MEDX","LU1551013425.SGD","LU0417517546.SGD","LU1366192091.USD","LLYZ","LU1868836914.USD","LU2746668974.SGD","LU0097036916.USD","LU0006306889.USD","IE00BKVL7J92.USD","LU2417539215.USD","LU0158827948.USD","LU0964807845.USD","LU0323591593.USD","BK4532","LU0203201768.USD","ELIS","LU2552382058.USD","LU1093756325.SGD","BK4599","SG9999015978.USD","LU0943347566.SGD","LU2063271972.USD","LU0471298777.SGD","LU2456880835.USD","LU2023250330.USD","LU1551013342.USD","LU2491049909.HKD","LU0471298694.HKD","LU2360106947.USD","LU0882574055.USD","LU0786609619.USD","LU0256863902.USD","LU0823434740.USD","LU1983299246.USD","RXL","LU0708995401.HKD","IE00BN29S564.USD","IE0005OL40V9.USD","LU2602419157.SGD","LU1989771016.USD","LU2237438978.USD","LU0823416689.USD","IE00B2B36J28.USD","LU2756315664.SGD","IE00B4R5TH58.HKD","LU2361045086.USD","IE00BKDWB100.SGD","IYH","LU2106854487.HKD","IE00BKPKM429.USD","SGXZ57979304.SGD","SG9999018857.SGD","LU2023250504.SGD","LU0456855351.SGD","LU0122379950.USD","LU0320765992.SGD","MHIP","BK4534","LU1712237335.SGD","LLII","IE00BJJMRX11.SGD","LU0106261372.USD","LU0289739699.SGD","LU1868837136.USD","LU0096364046.USD","LU1623119135.USD","IE0004445015.USD","LU2265009873.SGD","LU2357305700.SGD","WDNA","SG9999018865.SGD","IHE","LU0198837287.USD","IE00B7KXQ091.USD","NVO","SGXZ81514606.USD","XLV","SG9999001176.SGD","LU2750360641.GBP","TRUH","LU0061475181.USD","LU0109394709.USD","HRTS","SG9999015945.SGD","SG9999017495.SGD","LU0133085943.USD","VHT","LU2264538146.SGD","IE00BZ1G4Q59.USD","LU1291159041.SGD","LU1023059063.AUD","LU0109391861.USD","IE00BK4W5L77.USD","LU0256863811.USD","BK4585","LU2237443465.HKD","AGNG","LU0820561818.USD","LU2237443622.USD","LU0154236417.USD","NVOX","LU0889565916.HKD","LU0210536198.USD","LU1691799644.USD","IE00BFSS8Q28.SGD","LU1127390331.HKD","LU1057294990.SGD","SG9999014880.SGD","LU2236285917.USD","PPH","IE00BFSS7M15.SGD","LU1093756168.USD","IE0002141913.USD","LU1979441026.SGD","LU0354030438.USD","LU0683600562.USD","LU2087625088.SGD","ILDR","LU0882574139.USD","LU2491050154.USD","LU2896262040.SGD","LU0114720955.EUR","LU1548497426.USD","LU2237443549.SGD","LU2237443978.SGD","LU2361044949.HKD","LU2237443382.USD","LU1061106388.HKD","LU0820561909.HKD","BK4533","LU2213496289.HKD","SG9999014906.USD","LU2028103732.USD","LLYX","SG9999015986.USD","LU0079474960.USD","LU0432979614.USD","IE00BJJMRZ35.SGD","SG9999013999.USD","LU2111349929.HKD","LU0316494557.USD","LU0238689110.USD","LU0203202063.USD","LU0058720904.USD","THNR","LU2168564222.USD","LU0787776722.HKD","GDOC","IE00BFTCPJ56.SGD","LU1323610961.USD","LU0353189763.USD","LU1917777945.USD","MEDI","SG9999001176.USD","SGXZ31699556.SGD","LU0672654240.SGD","LU0266013472.USD","LU2471134796.USD","LU2552382215.SGD","TMED","BK4516","FTXH","LU2361044865.SGD","SG9999014898.SGD","SG9999014914.USD","LU1868837300.USD","LU2023251221.USD","IE0004445239.USD","NVOH","CURE","IXJ","LU0353189680.USD","IE00B4JS1V06.HKD","LU2237443895.HKD","LU1720051108.HKD","BK4007","LU0174119429.USD","LU2746668461.USD","LU1868836757.USD","ELIL","IE0001KFT4U8.USD","LU0385154629.USD","LU0345770993.USD","LU0689472784.USD","BK4581","LU2491050071.SGD","IE00BK4W5M84.HKD","LU0466842654.USD","LU1804176565.USD","LU1814569148.SGD","LU2168563687.JPY","LU1267930730.SGD","LU2168564149.EUR","BK4588","LU2089283258.USD","LU0640476718.USD","LU0345770308.USD","LU2089984988.USD","LU2471134952.CNY","LU2461242641.AUD","LU2324357040.USD","IE00B775H168.HKD","IE00B1XK9C88.USD","LU0823434583.USD","LLY","LU1974910355.USD","FHLC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673301492","title":"Cboe data suggests bullish flow in Novo Nordisk with shares up 1.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2673301492","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673301492?lang=en_us&edition=fundamental","pubTime":"2026-10-08 01:00","pubTimestamp":1791392420,"startTime":"0","endTime":"0","summary":"Cboe data suggests bullish flow in Novo Nordisk (NVO), with shares up 64c, or 1.69%, near $38.16. Options volume roughly in line with average with ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cboe-data-suggests-bullish-flow-in-novo-nordisk-with-shares-up-1-69-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cboe-data-suggests-bullish-flow-in-novo-nordisk-with-shares-up-1-69-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1093756325.SGD","BK4532","NVOH","NVO","IE00BKVL7J92.USD","LU1093756168.USD","IE00BZ1G4Q59.USD","NVOX","OZEM","PPH","BK4007","BK4599","BK4588","THNR","BK4585","LU0154236417.USD","NVOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673116150","title":"Novo Nordisk A/S Series B Stock Rises Wednesday, Outperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2673116150","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673116150?lang=en_us&edition=fundamental","pubTime":"2026-10-08 00:03","pubTimestamp":1791388980,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of Novo Nordisk A/S Series B advanced 3.4% to DKK253.90 Wednesday on what proved to be an overall unfavorable trading session for the stock market, with the OMX Nordic 40 Index falling 0.8% to 2,598.33.The stock's rise  snapped a four-day losing streak.The company closed DKK156.05 short of its 52-week high of DKK409.95, which the company achieved on January 23, 2026.Trading volume was 6,162,474, compared to the 50-day average trading volume of 5,007,609.Data source: Dow Jones Market Data, FactSet","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0154236417.USD","OZEM","BK4588","IE00BKVL7J92.USD","BK4532","LU1093756168.USD","NVO","BK4007","IE00BZ1G4Q59.USD","NVOX","PPH","BK4599","BK4585","NVOH","LU1093756325.SGD","NVOC","THNR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673115990","title":"Novo Nordisk call volume above normal and directionally bullish","url":"https://stock-news.laohu8.com/highlight/detail?id=2673115990","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673115990?lang=en_us&edition=fundamental","pubTime":"2026-10-07 23:45","pubTimestamp":1791387913,"startTime":"0","endTime":"0","summary":"Bullish option flow detected in Novo Nordisk (NVO) with 26,441 calls trading, 1.5x expected, and implied vol increasing over 1 point to 41.74%. Jan...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/novo-nordisk-call-volume-above-normal-and-directionally-bullish-thefly-news-4?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/novo-nordisk-call-volume-above-normal-and-directionally-bullish-thefly-news-4?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4532","LU1093756325.SGD","BK4585","BK4599","THNR","NVOX","IE00BZ1G4Q59.USD","NVOC","OZEM","NVO","PPH","BK4588","BK4007","LU1093756168.USD","LU0154236417.USD","NVOH","IE00BKVL7J92.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673301969","title":"European Equities Traded in US as ADRs Fall in Wednesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2673301969","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673301969?lang=en_us&edition=fundamental","pubTime":"2026-10-07 23:09","pubTimestamp":1791385793,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts fell late Wednesday morning with the S&P Europe Select ADR Index declining 1.2% to 1,875.05.From continental Europe, the gainers were led by medical device maker EDAP TMS  and pharmaceutical company Sanofi , which increased 3% and 0.8%, respectively. They were followed by pharmaceutical company Novo Nordisk  and biopharmaceutical company argenx , which were up 0.6% and 0.4%, respectively.The decliners from continental Europe were led by lender Banco Bilbao Vizcaya Argentaria  and biopharmaceutical company Cellectis , which decreased 3.9% and 3.6%, respectively. They were followed by lenders Banco Santander  and ING , which dropped 3.3% and 3.2%, respectively.The gainers from the UK were led by biopharmaceutical companies NuCana  and Mereo BioPharma Group , which advanced 3.8% and 3.3%, respectively. They were followed by telecommunications operator Vodafone Group  and tobacco company British American Tobacco , which ros","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE0002141913.USD","BK4132","02378","LU0390134368.USD","FOCL","LU0128525689.USD","LU2324357040.USD","PUK","OZEM","00005","VOD","BK4505","BDRX","LU0154236417.USD","THNR","IE0034235188.USD","LU0320765992.SGD","HSBH","BBVA","LU0052756011.USD","LU0006061336.USD","LU0823416689.USD","FMED","LU0496365809.HKD","LU1983260115.SGD","LU1093756168.USD","BK4532","NICO","BK4139","IE00BFTCPJ56.SGD","IE00BZ1G4Q59.USD","IE00BJT1NW94.SGD","NVOH","BK4521","IBB","MREO","NVO","ARGX","LU0211326755.USD","BK4082","LU0310800965.SGD","LU0109394709.USD","LU1093756325.SGD","IE00BFXG1179.USD","IE00BKVL7J92.USD","TRIB","LU0162691827.USD","LU0072461881.USD","GSIB","BK4075","BTI","LU0976567544.SGD","BK4162","LU2543165471.USD","ING","IE0009355771.USD","IE00B2B36J28.USD","IE00B4R5TH58.HKD","LU0889565916.HKD","LU0211326839.USD","TBXU","BK4588","CLLS","BK4207","LU2236285917.USD","BK4007","SNY","SAN","NVOX","LU1267930227.SGD","PPH","HSBC","BK4585","BK4599","NVOC","IE00BJJMRZ35.SGD","NCNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673096639","title":"Deutsche Bank  Keeps Their Sell Rating on Novo Nordisk (0QIU)","url":"https://stock-news.laohu8.com/highlight/detail?id=2673096639","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673096639?lang=en_us&edition=fundamental","pubTime":"2026-10-07 15:58","pubTimestamp":1791359924,"startTime":"0","endTime":"0","summary":"In a report released today, Emmanuel Papadakis from Deutsche Bank maintained a Sell rating on Novo Nordisk, with a price target of DKK225.00. Accor...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/deutsche-bank-keeps-their-sell-rating-on-novo-nordisk-0qiu-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/deutsche-bank-keeps-their-sell-rating-on-novo-nordisk-0qiu-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4599","BK4007","BK4588","BK4585","LU0154236417.USD","BK4532","THNR","IE00BZ1G4Q59.USD","PPH","OZEM","NVOX","LU1093756168.USD","LU1093756325.SGD","NVOH","IE00BKVL7J92.USD","NVOC","NVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179317192","title":"Why Vaxcyte Chose A 1.5% Convertible","url":"https://stock-news.laohu8.com/highlight/detail?id=1179317192","media":"Macro World","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179317192?lang=en_us&edition=fundamental","pubTime":"2026-10-07 14:39","pubTimestamp":1791355173,"startTime":"0","endTime":"0","summary":"","market":"nz","thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/3223.webp","type":0,"news_type":0,"thumbnails":["https://news-video-sg.skytigris.cn/videos/covers/3223.webp"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRK","NVOH","SNY","ELIL","ABBV","ELIS","VERU","VIR","NVOC","GSKH","NVOX","LLY","PFE","NVAX","BMY","LLII","MRNY","GSK","NVS","AZN","GILD","LLYX","BNTX","MRNX","NVO","JNJ","MRNA","REGN","PCVX","BIIB","ABT","AMGN"],"isVideo":true,"video":{"duration":118,"video_url":"https://news-video-sg.skytigris.cn/videos/cdn/3223.mp4","video_thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/3223.webp","audio_url":"https://static.tigerbbs.com/a3b4d121da19466383da6687bb50a205.mp3","isAI":true},"gpt_icon":0},{"id":"2673050352","title":"Novo Nordisk Probes Patient Priorities in German Hemophilia A Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2673050352","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673050352?lang=en_us&edition=fundamental","pubTime":"2026-10-07 00:31","pubTimestamp":1791304305,"startTime":"0","endTime":"0","summary":"Novo Nordisk ($NVO) announced an update on their ongoing clinical study. Novo Nordisk Tests What Matters Most to Hemophilia A Patients in Germany. ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/novo-nordisk-probes-patient-priorities-in-german-hemophilia-a-study?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/novo-nordisk-probes-patient-priorities-in-german-hemophilia-a-study?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","IE00BKVL7J92.USD","LU1093756325.SGD","LU1093756168.USD","BK4532","BK4588","IE00BZ1G4Q59.USD","NVOX","NVOH","BK4599","OZEM","PPH","NVO","NVOC","BK4007","THNR","LU0154236417.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130787623","title":"From Lilly Deal to Market Darling: Inside Ginkgo's 120% Monthly Run","url":"https://stock-news.laohu8.com/highlight/detail?id=1130787623","media":"Bellwether Stocks Movement","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130787623?lang=en_us&edition=fundamental","pubTime":"2026-10-06 10:42","pubTimestamp":1791254527,"startTime":"0","endTime":"0","summary":"","market":"sg","thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/3157.webp","type":0,"news_type":0,"thumbnails":["https://news-video-sg.skytigris.cn/videos/covers/3157.webp"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"From Lilly Deal to Market Darling: Inside Ginkgo's 120% Monthly Run","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMY","ELIL","REGN","NVOX","SNY","LLII","BIIB","ELIS","GSK","JNJ","NVAX","ABBV","NVO","SBIO","MRNX","AZN","NVS","PFE","NVOC","VIR","DNA","LLY","BNTX","IDNA","NVOH","ABT","MRNY","MRNA","VERU","XBI","AMGN","GERM","LLYX","MRK","GILD","GSKH"],"isVideo":true,"video":{"duration":153,"video_url":"https://news-video-sg.skytigris.cn/videos/cdn/3157.mp4","video_thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/3157.webp","audio_url":"https://static.tigerbbs.com/bf2704fcb2c9a829b788528d676b3500.mp3","isAI":true},"gpt_icon":0},{"id":"2673086789","title":"Cboe data shows mixed options sentiment in Novo Nordisk with shares down 0.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2673086789","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673086789?lang=en_us&edition=fundamental","pubTime":"2026-10-06 01:15","pubTimestamp":1791220511,"startTime":"0","endTime":"0","summary":"Cboe data shows mixed options sentiment in Novo Nordisk (NVO), with shares down 18c near $37.15. Options volume relatively light with 24k contracts...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cboe-data-shows-mixed-options-sentiment-in-novo-nordisk-with-shares-down-0-47-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cboe-data-shows-mixed-options-sentiment-in-novo-nordisk-with-shares-down-0-47-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BKVL7J92.USD","NVOH","IE00BZ1G4Q59.USD","LU0154236417.USD","NVO","THNR","LU1093756325.SGD","BK4007","BK4532","LU1093756168.USD","OZEM","BK4585","PPH","NVOC","BK4599","NVOX","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673085403","title":"Novo Nordisk A/S Series B Stock Falls Monday, Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2673085403","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673085403?lang=en_us&edition=fundamental","pubTime":"2026-10-06 00:03","pubTimestamp":1791216180,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of Novo Nordisk A/S Series B shed 0.8% to DKK246.80 Monday on what proved to be an overall mediocre trading session for the stock market, with the OMX Nordic 40 Index holding steady at 2,595.90.This was the stock's third consecutive day of losses.The company closed DKK163.15 below its 52-week high of DKK409.95, which the company achieved on January 23, 2026.Trading volume was 5,784,986, compared to the 50-day average trading volume of 4,924,415.Data source: Dow Jones Market Data, FactSet","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","IE00BZ1G4Q59.USD","LU1093756168.USD","NVO","LU0154236417.USD","NVOX","BK4585","PPH","OZEM","BK4007","LU1093756325.SGD","THNR","NVOH","BK4532","BK4599","IE00BKVL7J92.USD","NVOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673029387","title":"J.P. Morgan Sticks to Their Hold Rating for Novo Nordisk (0QIU)","url":"https://stock-news.laohu8.com/highlight/detail?id=2673029387","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673029387?lang=en_us&edition=fundamental","pubTime":"2026-10-05 19:56","pubTimestamp":1791201382,"startTime":"0","endTime":"0","summary":"In a report released today, Richard Vosser from J.P. Morgan maintained a Hold rating on Novo Nordisk, with a price target of DKK275.00. According t...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/j-p-morgan-sticks-to-their-hold-rating-for-novo-nordisk-0qiu-blurbs-news-3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/j-p-morgan-sticks-to-their-hold-rating-for-novo-nordisk-0qiu-blurbs-news-3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4532","BK4588","OZEM","NVO","IE00BKVL7J92.USD","NVOX","THNR","BK4599","BK4585","IE00BZ1G4Q59.USD","LU1093756325.SGD","LU1093756168.USD","NVOC","LU0154236417.USD","NVOH","PPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673415703","title":"Novo Nordisk Could Raise Guidance Alongside Strong Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2673415703","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673415703?lang=en_us&edition=fundamental","pubTime":"2026-10-05 16:03","pubTimestamp":1791187380,"startTime":"0","endTime":"0","summary":"0802 GMT - Novo Nordisk will likely report a strong set of third-quarter results and raise full-year guidance, J. P. Morgan analysts write. The bank forecasts adjusted sales of 76 billion Danish kroner, 4% ahead of Bloomberg consensus. It expects injectable Wegovy sales of 21.5 billion kroner, 9% ahead of consensus, reflecting continued growth in sales outside the U.S. Oral Wegovy sales are seen at 5.3 billion kroner, 19% ahead of views, as it says consensus seems to be underestimating sales outside the U.S. Ozempic sales are seen at 26.6 billion kroner, 7% ahead of consensus. Adjusted operating profit is seen at 30 billion kroner. The bank also expects Novo to raise its constant exchange rate guidance for adjusted sales and adjusted operating profit to minus 3% to plus 1%, from 0% to minus 6%. Shares fall 1.5%.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4532","BK4588","OZEM","NVO","IE00BKVL7J92.USD","NVOX","THNR","BK4599","BK4585","IE00BZ1G4Q59.USD","LU1093756325.SGD","LU1093756168.USD","NVOC","LU0154236417.USD","NVOH","PPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124786704","title":"Merck Doubled Off Its Lows — And Analysts Still See More Room","url":"https://stock-news.laohu8.com/highlight/detail?id=1124786704","media":"Bellwether Stocks Movement","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1124786704?lang=en_us&edition=fundamental","pubTime":"2026-10-05 14:41","pubTimestamp":1791182489,"startTime":"0","endTime":"0","summary":"","market":"hk","thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/3135.webp","type":0,"news_type":0,"thumbnails":["https://news-video-sg.skytigris.cn/videos/covers/3135.webp"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Merck Doubled Off Its Lows — And Analysts Still See More Room","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QQQ","SDOW","BNTX","MMAX","GSK","SPYH","DMAX",".IXIC","NVOH","SPYQ","TQQQ","SQQQ","ELIL","JPO","SNY","ELIS","NVOX","SH","VOO","MRNA","UDOW","NVOC","SPYM","LLII","HIBL","SPXU","LLYX",".SPX","SPXL","SSO","AZN","VIR","BMY","JPM","NVS","MRNY","DXD","SMAX","BIIB","DDM","NVO","REGN","YSPY","SPUU","LLY","ABT","GILD","SPY","SDS","JPMO","DIA","ABBV","IVV","NVAX","VERU","MRNX",".DJI","DOG","PFE","MRK","SPYU","SPDN","SPXS","JNJ","AMGN","UPRO","GSKH"],"isVideo":true,"video":{"duration":182,"video_url":"https://news-video-sg.skytigris.cn/videos/cdn/3135.mp4","video_thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/3135.webp","audio_url":"https://static.tigerbbs.com/d492d9882b1cd5d0c5306026a8f1963f.mp3","isAI":true},"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}]}}